(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)
By Amy Dockser Marcus
Here's what's happening in health news this morning:
J&J To Stop Selling Surgical Mesh (WSJ): Johnson & Johnson says it will stop selling its version of a surgical mesh product used to treat a painful pelvic condition in women.
Sex Bug Growing Resistant to Drugs, WHO Warns (AP): Gonorrhea, a sexually transmitted disease that infects millions, is growing resistant to drugs, raising worries among health officials that in a few years, it could become untreatable.
FDA Rejects Merck's Treatment for Bone Cancer (WSJ): The FDA rejected a new drug application for ridaforolimus, a bone cancer treatment, saying further trials are needed to assess the drug's effectiveness and safety.
Depressed? Treatment May Be A Phone Call Away (NPR Shots): Researchers at Northwestern University Feinberg School of Medicine found that people with major depression who received 18 weeks of talk therapy over the phone showed similar improvement to those who received the therapy in person, according to a study published in the Journal of the American Medical Association.
Exercise Benefits Black Girls Less Than Whites, Study Shows (LA Times): A study published in the Archives of Pediatrics and Adolescent Medicine compared white and black girls' physical activity and food intake and found that black adolescent girls don't appear to benefit as much from the effects of physical activity in preventing obesity as white peers.
-For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.
(END) Dow Jones Newswires
June 06, 2012 09:31 ET (13:31 GMT)
Copyright (c) 2012 Dow Jones & Company, Inc.